United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Sensei Biotherapeutics, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -58.4% | -1.45% | -1.47% | -1.49% | -1.52% | -1.54% |
|---|---|---|---|---|---|---|
| ROA | -50.37% | -1.22% | -1.22% | -1.22% | -1.22% | -1.22% |
| Total Assets | $45,361.00K | $45,361.00K | $45,361.00K | $45,361.00K | $45,361.00K | $45,361.00K |
| Net Income | -$30,157.00K | -$552.00K | -$552.15K | -$552.32K | -$552.52K | -$552.75K |